Anti-human platelet antigen antibodies (Trx-HPA-1a) Aptamer Details
ID# 7786
Structure
Chemistry
Peptide
Target
Anti-human platelet antigen antibodies (HPA-1a)
Category
Protein
Affinity (Kd)
N/A nM
Length
133
Aptazyme
No
Sequence (3-char table code)
G
A
C
U/T
5'-MetMetSerAspLys IleIleHisLeuThr AspAspSerPheAsp ThrAspValLeuLys AlaAspGlyAlaIle LeuValAspPheTrp AlaGluTrpCysGly ProValValAlaGly AspAspProArgGlu AspThrTrpGlyPro CysLysMetIleAla ProIleLeuAspGlu IleAlaAspGluTyr GlnGlyLysLeuThr ValAlaLysLeuAsn IleAspGlnAsnPro GlyThrAlaProLys TyrGlyIleArgGly IleProThrLeuLeu LeuPheLysAsnGly GluValAlaAlaThr LysValGlyAlaLeu SerLysGlyGlnLeu LysGluPheLeuAsp AlaAsnLeuValAsp LeuGlnHisHisHis HisHisHis-3'
Molecular Weight: 16956.67
Extinction Coefficient:
Binding Conditions / Buffer
Buffer for ELISA assay: PBS.
Binding Temp: 20-25°C
Refolding Protocol
If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Reference
J Thibaut et al. A novel assay for the detection of anti-human platelet antigen antibodies (HPA-1a) based on peptide aptamer technology. haematologica 97(2012): 696-704.
Request a Quote
Have your aptamer oligo synthesized by Aptagen.
